A British American Tobacco (BAT) subsidiary is investing a further CAD124.6m (USD90.2m) in its strategic partnership with Canadian licensed cannabis producer Organigram.
The investment will be through 38.7m shares to be issued over three tranches. BAT will also increase its equity position from around 19% to 45%.
...Are you already a subscriber? login here